Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Sharkey

Showing results (41-50 of 145) with videos related to

Pageof 15
Sort By:
Cancer Research|February 1, 1990
Use of hematopoietic growth factors to control myelosuppression caused by radioimmunotherapyR D Blumenthal, R M Sharkey, L M Quinn, et al.
International Journal of Cancer|January 27, 1997
Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in miceR M Alisauskas, D M Goldenberg, R M Sharkey, et al.
Cancer|September 1, 1978
Immunoperoxidase detection of carcinoembryonic antigen: an overviewF J Primus, R M Sharkey, H J Hansen, et al.
Cancer Research|July 1, 1986
A human colon cancer metastasis model for radioimmunodetectionR M Sharkey, D Filion, I Fand, et al.
Glycobiology|October 6, 1997
Structure determination of N-linked oligosaccharides engineered at the CH1 domain of humanized LL2Z Qu, R M Sharkey, H J Hansen, et al.
Cancer|December 24, 1997
Defining the optimal spacing between repeat radioantibody doses in experimental models: is there an accurate measurement for hematopoietic recovery?R D Blumenthal, R Alisauskas, M Juweid, et al.
Cancer|February 1, 1994
Cytokine intervention permits dose escalation of radioantibody. An analysis of myelostimulation by bolus versus continuous infusion of IL-1/GM-CSFR D Blumenthal, R M Sharkey, D Forman, et al.
Cancer Research|December 1, 1995
Estimates of red marrow dose by sacral scintigraphy in radioimmunotherapy patients having non-Hodgkin's lymphoma and diffuse bone marrow uptakeM Juweid, R M Sharkey, J A Siegel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-pR D Blumenthal, R Kashi, R Stephens, et al.
Experimental Hematology|August 7, 1998
Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppressionR D Blumenthal, R Alisauskas, W Lew, et al.
Pageof 15

Showing results (41-50 of 145) with videos related to

Sort By:
Pageof 15
Cancer Research|February 1, 1990
Use of hematopoietic growth factors to control myelosuppression caused by radioimmunotherapyR D Blumenthal, R M Sharkey, L M Quinn, et al.
International Journal of Cancer|January 27, 1997
Reduction in the duration of myelotoxicity associated with radioimmunotherapy with infusions of the hemoregulatory peptide, HP5b in miceR M Alisauskas, D M Goldenberg, R M Sharkey, et al.
Cancer|September 1, 1978
Immunoperoxidase detection of carcinoembryonic antigen: an overviewF J Primus, R M Sharkey, H J Hansen, et al.
Cancer Research|July 1, 1986
A human colon cancer metastasis model for radioimmunodetectionR M Sharkey, D Filion, I Fand, et al.
Glycobiology|October 6, 1997
Structure determination of N-linked oligosaccharides engineered at the CH1 domain of humanized LL2Z Qu, R M Sharkey, H J Hansen, et al.
Cancer|December 24, 1997
Defining the optimal spacing between repeat radioantibody doses in experimental models: is there an accurate measurement for hematopoietic recovery?R D Blumenthal, R Alisauskas, M Juweid, et al.
Cancer|February 1, 1994
Cytokine intervention permits dose escalation of radioantibody. An analysis of myelostimulation by bolus versus continuous infusion of IL-1/GM-CSFR D Blumenthal, R M Sharkey, D Forman, et al.
Cancer Research|December 1, 1995
Estimates of red marrow dose by sacral scintigraphy in radioimmunotherapy patients having non-Hodgkin's lymphoma and diffuse bone marrow uptakeM Juweid, R M Sharkey, J A Siegel, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-pR D Blumenthal, R Kashi, R Stephens, et al.
Experimental Hematology|August 7, 1998
Myelosuppressive changes from single or repeated doses of radioantibody therapy: effect of bone marrow transplantation, cytokines, and hematopoietic suppressionR D Blumenthal, R Alisauskas, W Lew, et al.
Pageof 15